1196541-47-5 Usage
General Description
The chemical "(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide" is a cyclopropane derivative that contains a 1H-pyrrolo[2,3-b]pyridine ring system. It also contains an aminopiperidine moiety and a bromine atom. (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide is a chiral molecule, with the (R) configuration. It may have potential pharmaceutical applications due to its structural features and biological activity. The presence of the cyclopropane and pyrrolopyridine moieties could make it of interest for drug discovery and development programs targeting various biological pathways. Further research and study are necessary to fully understand the properties and potential applications of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1196541-47-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,6,5,4 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1196541-47:
(9*1)+(8*1)+(7*9)+(6*6)+(5*5)+(4*4)+(3*1)+(2*4)+(1*7)=175
175 % 10 = 5
So 1196541-47-5 is a valid CAS Registry Number.
1196541-47-5Relevant articles and documents
An Efficient Through-Process for Chk1 Kinase Inhibitor GDC-0575
Han, Chong,Green, Keena,Oehring, Kathrin,Meili, Arthur,Pfeifer, Eugen,Scalone, Michelangelo,Gosselin, Francis
, p. 344 - 350 (2018)
We report an efficient route to prepare Chk1 kinase inhibitor GDC-0575 from 5-bromo-4-chloro-3-nitro-7-azaindole featuring a sequence of nucleophilic aromatic substitution, hydrogenative nitro-reduction, and a robust, high-yielding end-game involving deprotection-crystallization steps. The developed route was demonstrated on 10 kg scale in 30% overall yield to provide the target API in >99.8 A % HPLC purity.
PROCESS FOR PREPARING A COMPOUND
-
, (2015/03/13)
The invention provides processes of preparation thereof useful in the preparation of compounds that can be used as CHK1 inhibitors.